DLL3 and neoplasm: While DLL3 inhibition with SC16LD6.5 markedly inhibited tumor growth in NEPC cell lines and PDX models, DLL3 was not identified as a master regulator for NEtD, as its inhibition did not consistently decrease NE markers.